SITC Resource Library

SITC 2019 Annual Meeting: Concurrent Session 310: Combination Phase 1-2 Clinical Trials 

10-24-2019 10:58

The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 310: Combination Phase 1-2 Clinical Trials" during the SITC 2019 Annual Meeting on November 9, 2019. Available here are the presentation slides and video from the session.

 

34th Annual Meeting Organizers

  • Ana Carrizosa Anderson, PhD – Harvard Medical School
  • Marianne Davies, DNP, AOCNP – Yale School of Nursing
  • Stefani Spranger, PhD – Koch Institute for Integrative Cancer Research at MIT
  • Ahmad A. Tarhini, MD, PhD – Emory University and Winship Comprehensive Cancer Center


Session Co-Chairs

  • Adil Daud, MBBS, MD – University of California, San Francisco
  • Howard Streicher, MD – National Cancer Institute


To view the entire program schedule (including presenter permission to post) please click here.

Statistics
0 Favorited
108 Views
10 Files
0 Shares
305 Downloads

 Video
Attachment(s)
pdf file
"Clinical activity of BEMPEG plus NIVO in previously untr...   1.39 MB   1 version
Uploaded - 11-13-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Adi Diab, MD – The University of Texas MD Anderson Cancer Center; Date: November 9, 2019
mp4 file
"Clinical activity of BEMPEG plus NIVO in previously untr...   278.77 MB   1 version
Uploaded - 12-06-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Adi Diab, MD – The University of Texas MD Anderson Cancer Center; Date: November 9, 2019
pdf file
"A pilot study of engineered adenovirus ONCOS-102 in comb...   1.33 MB   1 version
Uploaded - 11-13-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Alexander N. Shoushtari, MD – Memorial Sloan Kettering Cancer Center; Date: November 9, 2019
mp4 file
"A pilot study of engineered adenovirus ONCOS-102 in comb...   323.49 MB   1 version
Uploaded - 12-06-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Alexander N. Shoushtari, MD – Memorial Sloan Kettering Cancer Center; Date: November 9, 2019
pdf file
"Phase II trial of concurrent nivolumab and radiation the...   1.06 MB   1 version
Uploaded - 11-13-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Ulka N. Vaishampayan, MD – Wayne State University and Barbara Ann Karmanos Cancer Institute; Date: November 9, 2019
mp4 file
"Phase II trial of concurrent nivolumab and radiation the...   261.60 MB   1 version
Uploaded - 12-06-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Ulka N. Vaishampayan, MD – Wayne State University and Barbara Ann Karmanos Cancer Institute; Date: November 9, 2019
pdf file
"Avelumab and cetuximab in combination with FOLFOX in pat...   934 KB   1 version
Uploaded - 11-13-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Joseph Tintelnot, MD – University Medical Center Hamburg-Eppendorf; Date: November 9, 2019
mp4 file
"Avelumab and cetuximab in combination with FOLFOX in pat...   262.92 MB   1 version
Uploaded - 12-06-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Joseph Tintelnot, MD – University Medical Center Hamburg-Eppendorf; Date: November 9, 2019
pdf file
"Sitravatinib in combination with nivolumab demonstrates ...   3.80 MB   1 version
Uploaded - 11-13-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Pavlos Msaouel, MD, PhD – The University of Texas MD Anderson Cancer Center; Date: November 9, 2019
mp4 file
"Sitravatinib in combination with nivolumab demonstrates ...   307.12 MB   1 version
Uploaded - 12-06-2019
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Pavlos Msaouel, MD, PhD – The University of Texas MD Anderson Cancer Center; Date: November 9, 2019

Related Entries and Links

No Related Resource entered.